Brief: Societal Cdmo Enters Agreement With Atossa Therapeutics To Provide Clinical Trial Services (CTS)
23/05/2023 12:35
May 23 (Reuters) - Atossa Therapeutics Inc ATOS.O :
* SOCIETAL CDMO ENTERS AGREEMENT WITH ATOSSA THERAPEUTICS TO
PROVIDE CLINICAL TRIAL SERVICES (CTS) FOR INNOVATIVE SELECTIVE
ESTROGEN RECEPTOR MODULATOR
Source text for Eikon: ID:nGNX2jHfzm
Further company coverage: ATOS.O
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Societal CDMO
See all newsBrief: Corerx Inc Completes Acquisition Of Societal CDMO Inc
Societal CDMO Inc reports results for the quarter ended in December - Earnings Summary
Brief: Societal CDMO Inc Received Notice From Nasdaq Stating Co Regained Compliance With Nasdaq Listing Rule 5550(A)(2) On March 14
Brief: Societal Cdmo Enters Into Definitive Agreement To Be Acquired By Corerx, Inc.
Societal CDMO Inc expected to post a loss of 1 cent a share - Earnings Preview